Huw M. Nash, Chief Business Officer at Stoke Therapeutics, Inc. (STOK), sold 2,500 shares at $13.90 ($33K) on 2024-07-02, disclosed to the SEC on 2024-07-03.
Scheduled sale ($33k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.10 | 2,467 | $32K | 98.6% |
| 2 | $13.90 | 33 | $459 | 1.4% |
| Total | $13.11 avg | 2,500 | $33K | 100% |
| Filing → |
| STOK | SELL | 2024-03-19 | $25K | — | Filing → |
| STOK | SELL | 2022-01-05 | $88K | — | Filing → |
| STOK | SELL | 2021-12-03 | $139K | — | Filing → |